SCCM Neuroscience Section
@SCCM_Neuro
Followers
1K
Following
675
Media
224
Statuses
496
The @SCCM_Neuro Section offers networking, education, and professional development. Posts are managed by the section do not reflect the views of @SCCM
Joined January 2022
SAVE THE DATE! The @SCCM Neuroscience Section will hold a virtual business meeting on Thursday, November 20, 2025, 3:30-4:30PM CST. All members are welcome to attend - learn about section activities and find out how you can get involved! Zoom link on SCCM Connect. #SCCMNeuro
0
2
5
🔍 In the 2014–2017 Approaches and Decisions in Acute Pediatric TBI (ADAPT) study cohort, children with severe TBI were at a significant risk of elevated intracranial pressure. ➡️ Read more in the November issue of PCCM: https://t.co/Vpk2XNxvPR
#PedsICU #SCCM @SCCM
0
5
6
Meet Dr. Rajeev Garg, Past Chair of our Section Steering Committee ! Join him and the rest of the Section Leadership at our virtual Business Meeting on Thursday, November 20, 2025, 3:30-4:30PM CST (Zoom link on @SCCM Connect). #SCCMNeuro #NeuroICU🧠
0
0
2
Meet Dr. Sahar Zafar, Secretary/Treasurer of our Section Steering Committee ! Join her and the rest of the Section Leadership at our virtual Business Meeting on Thursday, November 20, 2025, 3:30-4:30PM CST (Zoom link on @SCCM Connect). #SCCMNeuro #NeuroICU🧠
0
1
2
Meet the members of our Section Steering Committee with Chair-Elect, Dr. Asma Zakaria! Join her and the rest of the Section Leadership at our virtual Business Meeting on Thursday, November 20, 2025, 3:30-4:30PM CST (Zoom link on @SCCM Connect). #SCCMNeuro #NeuroICU 🧠
0
2
4
Meet the members of our Section Steering Committee starting with our Chair, Dr. Aarti Sarwal! Join her and the rest of the Section Leadership at our virtual Business Meeting on Thursday, November 20, 2025, 3:30-4:30PM CST (Zoom link on @SCCM Connect). #SCCMNeuro #NeuroICU 🧠
0
2
13
After implementing active blood clearance & delayed cerebral ischemia prevention (ABCD) for high-risk aSAH patients, delayed cerebral infarctions decreased by 70% compared with the before-ABCD cohort.🧠 https://t.co/nGn9a5PDdf
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
4
12
Bedside cerebral autoregulation monitoring represents a promising approach for personalizing hemodynamic management in critically ill patients.🧠 https://t.co/pZiOA1kXid
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
12
24
We propose the use of the ICH checklist with the goal of harmonization and consistent delivery of evidence-based care that might improve the natural history of this devastating disease.🧠 https://t.co/wztN8B8epA
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
1
6
11
Use of new oral anticoagulants (NOACs) in cerebral venous sinus thrombosis (CVST) has similar efficacy & safety compared to warfarin treatment. NOACs treatment may improve clinical prognosis in pts with CVST.🧠 https://t.co/RnQEMPoq7C
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
1
7
14
Results suggest that 0° head positioning for patients with acute LVO was a protective maneuver to maintain clinical stability in the prethrombectomy phase while awaiting definitive treatment. 🧠 https://t.co/3qnkhN0UDE
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
4
12
This article on palliative care reviews latest research, offers strategies to approach difficult communication tasks w/ insufficient evidence to guide practice, & discusses ethical issues relevant to decision-making. 🧠 https://t.co/37y19ZPwCU
#SCCMNeuro #NeuroICU #NeuroTwitter
0
0
1
#Nimodipine-induced BP reductions below personalized limits of autoregulation may be associated with worse functional outcome after aSAH. 🧠 https://t.co/LoTKQusYkk
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
1
10
18
Despite statistically higher odds of achieving hemostatic efficacy with andexanet, we also observed higher odds of a thrombotic event with no difference in discharge outcomes observed between groups.🧠 https://t.co/y4HXMUIWu8
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
4
6
Reversal of subtherapeutic warfarin w/ acute spontaneous ICH & INR 1.5-1.9 was not associated w/ improvement in functional outcome based on discharge mRS score of 0-3 vs 4-6.🧠 https://t.co/zysCRUvHeZ
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
3
8
Join us for the next @SCCM Webcast on Thursday, November 6, 2025, 1-2PM CST! Advances in Seizure and Status Epilepticus Management in the ICU 🧠 Register here: https://t.co/teGSFUxJa4
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
6
9
Pain as evaluated by a commonly used score in the ICU (CPOT score) is common and its burden correlated consciousness and functional recovery at 3, 6, and 12 months in acute brain injury patients with DoC. 🧠 https://t.co/jqWT0XwiqG
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
1
3
GLP-1-RAs were associated with improved survival and fewer complications across stroke subtypes, plus reduced hemorrhagic and ischemic stroke incidence. 🧠 https://t.co/G1VcMegE8k
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
3
5
It's National #Pharmacy Week and today is Pharmacy Technician Day! Thanks to our critical care pharmacist colleagues and pharmacy technicians for all that they do for patient care!!!🧠 ❤️@SCCM_CPP
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
#PharmICU
0
1
2
TNK improves excellent outcomes & recanalization in pts w/ acute stroke treated w/i 4.5-24h, w/o increasing symptomatic ICH or mortality, and provides greater additional benefits when EVT is inaccessible.🧠 https://t.co/ebaDGhZpzh
#SCCMNeuro #NeuroICU #NeuroTwitter #NeuroX
0
17
29